In addition, although we did not have the statistical power to demonstrate an association with TILs in POLE-mutated colorectal tumors, we speculate that they could be responsive to checkpoint inhibition based on their increased neoantigen load. The gene discussed is POLE; the disease is colorectal neoplasm.